85293-12-5 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-methoxybenzyl)hydrazine is utilized as a key intermediate in the synthesis of pharmaceuticals for its potential role in the development of new drugs. Its unique structure allows for the creation of molecules with specific therapeutic properties, making it a valuable component in medicinal chemistry.
Used in Organic Synthesis:
In the realm of organic synthesis, 1-(3-methoxybenzyl)hydrazine serves as a versatile reagent for the preparation of various organic compounds. Its functional groups facilitate multiple types of chemical reactions, contributing to the synthesis of a wide array of molecules with different applications.
Used in Research and Development:
1-(3-methoxybenzyl)hydrazine is also employed in research and development settings to explore its chemical properties and potential applications. 1-(3-methoxybenzyl)hydrazine's structure offers opportunities for innovation in chemical processes and the discovery of new uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 85293-12-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,2,9 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 85293-12:
(7*8)+(6*5)+(5*2)+(4*9)+(3*3)+(2*1)+(1*2)=145
145 % 10 = 5
So 85293-12-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H12N2O/c1-11-8-4-2-3-7(5-8)6-10-9/h2-5,10H,6,9H2,1H3
85293-12-5Relevant academic research and scientific papers
ADENOSINE A2A RECEPTOR ANTAGONISTS
-
Page/Page column 7, (2008/12/04)
Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein: X1 and X2 are 1-3 substituents independently selected from the group consisting of H, alkyl, halo, —CF3, —OCF3, alkoxy, —OH and —CN;n is 0, 1 or 2; andR and R1 are H or alkyl; also disclosed is the use of the compounds in the treatment of CNS diseases such as Parkinson's disease, alone or in combination with other agents for treating CNS diseases, pharmaceutical compositions comprising them and kits comprising the components of the combinations.
4,5-dihydro-[1H]-benz[g]indazole-3-carboxylic acid derivatives
-
, (2008/06/13)
4,5-Dihydro-[1H]-benz[g]indazole-3-carboxylic acid derivatives represented by the following formula, or their salts, have excellent antagonism to endothelin receptors and are useful as preventives or remedies for diseases such as hypertension, angina pect
